Condensate biology: advancing drug discovery for complex diseases
Drug Target Review
JULY 13, 2023
Dewpoint Therapeutics, a platform drug discovery company founded in 2018, has been at the forefront of this exciting field. Dr Isaac Klein, Chief Scientific Officer at Dewpoint, brings a wealth of knowledge and expertise to the field of drug discovery. Klein notes the importance of Dewpoint’s disease-agnostic approach.
Let's personalize your content